BACKGROUNDInternal malignancies such as breast cancer, as well as their treatment can
often result in skin changes.OBJECTIVETo assess the prevalence of dermatological complaints in patients who are
undergoing oncological treatment for breast cancer in a hospital in
Tubarão, Santa Catarina, Brazil.METHODSObservational, cross-sectional study, from October 2015 to February 2016 in
which 152 patients with the diagnosis of breast cancer, undergoing treatment
with chemotherapy, radiotherapy, hormone therapy and/or surgery, were
interviewed and completed a research protocol developed by the author.RESULTSThe treatment of breast cancer was associated with dermatological complaints
in 94.1% of the interviewed, being with hair loss the most frequent, present
in 79.6% of the sample, followed by nail changes (56%). Patients with
lighter skin phototypes (I, II and III) had a lower risk (p=0.045) of
developing skin changes when compared to darker phototypes. Radiation
therapy (p=0.011) and oncological surgery (pFisher=0.004) were statistically
significant when related to skin changes.STUDY LIMITATIONSInherent to the design of the study, as well as recall bias.CONCLUSIONSIt was found that most patients diagnosed with breast cancer showed
dermatologic manifestations during the proposed cancer treatment. Patients
undergoing radiotherapy and surgery showed skin changes with greater
statistical significance.